U.S. markets closed

Dynatronics Corporation (DYNT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.2800-0.1000 (-7.25%)
At close: 4:00PM EST

1.2800 0.00 (0.00%)
After hours: 7:55PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close1.3800
Bid1.2600 x 4000
Ask1.3000 x 4000
Day's Range1.2600 - 1.3400
52 Week Range0.5200 - 2.6700
Avg. Volume1,929,430
Market Cap19.167M
Beta (5Y Monthly)-0.14
PE Ratio (TTM)N/A
EPS (TTM)-0.4050
Earnings DateFeb 11, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more

    Dynatronics Corporation Announces Extension of Key Distribution Agreement

    Bird & Cronin Renews Group Purchasing Agreement with Intalere for Orthopedic Soft Goods and BracingEAGAN, MN / ACCESSWIRE / February 24, 2021 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, announced today that its wholly-owned subsidiary, Bird & Cronin, LLC, renewed its purchasing agreement with Intalere, one of the leading national group purchasing organizations in the healthcare industry. The new agreement which extends the partnership through January 2024 was also announced by Intalere at https://www.

  • Benzinga

    Recap: Dynatronics Q2 Earnings

    Shares of Dynatronics (NASDAQ:DYNT) moved higher by 3.4% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 20.00% over the past year to ($0.06), which missed the estimate of ($0.05). Revenue of $11,968,000 declined by 21.25% year over year, which missed the estimate of $12,400,000. Guidance Earnings guidance hasn't been issued by the company for now. Dynatronics hasn't issued any revenue guidance for the time being. Details Of The Call Date: Feb 11, 2021 View more earnings on DYNT Time: 08:30 AM ET Webcast URL: https://www.webcaster4.com/Webcast/Page/2226/39738 Recent Stock Performance 52-week high: $3.70 Company's 52-week low was at $0.52 Price action over last quarter: Up 173.05% Company Profile Dynatronics Corp is a United States-based company that is engaged in designing, manufacturing, and distributing advanced-technology medical devices, therapeutic and medical treatment tables, rehabilitation equipment, custom athletic training treatment tables and equipment, institutional cabinetry as well as other rehabilitation and therapy products and supplies. The company markets and sells its products to physical therapists, chiropractors, athletic trainers, sports medicine practitioners, and other medical professionals and institutions. It offers customers a one-stop-shop for their medical equipment and supply needs, including electrotherapy, therapeutic ultrasound, phototherapy, rehabilitation products, treatment tables, customized training room products, and exercise products. See more from BenzingaClick here for options trades from BenzingaEarnings Scheduled For February 11, 2021Earnings Outlook for Dynatronics© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


    Dynatronics Reports Second Quarter Results

    EAGAN, MN / ACCESSWIRE / February 11, 2021 /Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced financial results for its second quarter of fiscal year 2021 for the period ended December 31, 2020.Fiscal Q2 2021 Financial Highlights * Net sales of $12 million were steady with net sales of $12 million in the prior quarter * Selling, general, and administrative expenses of $3.